HF
WHWK

HRT Financial’s Whitehawk Therapeutics WHWK Stock Holding History

HRT Financial’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Buy
+34,935
New +$109K ﹤0.01% 3317
2024
Q3 		– Sell
-28,172
Closed -$41K – 3298
2024
Q2 		$41K Buy
+28,172
New +$52.2K ﹤0.01% 1862
2022
Q4 		– Sell
-31,737
Closed -$448K – 3307
2022
Q3 		$448K Sell
31,737
-20,385
-39% -$268K ﹤0.01% 1712
2022
Q2 		$642K Buy
+52,122
New +$774K 0.01% 1309

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

HRT Financial's WHWK Position: Q1 2026 in Review

HRT Financial opened a new position in Whitehawk Therapeutics (WHWK) in Q1 2026: 34,935 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #3317 among its holdings. This is a return to the name: HRT Financial previously reported a position in WHWK as recently as Q2 2024.

HRT Financial first reported a position in WHWK in Q2 2022 and has held it in 4 quarters since. The position peaked at $642K in Q2 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • HRT Financial held 34,935 shares of Whitehawk Therapeutics worth $120K as of Q1 2026.
  • Whitehawk Therapeutics was a new HRT Financial position in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3317 holding.
  • HRT Financial first reported a position in Whitehawk Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • HRT Financial's Whitehawk Therapeutics position peaked at $642K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.